Project video launched for Cancer Immunotherapy month

Jun 22, 2022


To help raise awareness of mRNA based therapies the TIGER project are launching our simple explainer video available in 5 languages introducing this exciting new therapy for HPV16+ cancers.






About Cancer Immunotherapy

Immunotherapy treatments harness the body’s natural inbuilt defences – the immune system, to effectively prevent, control and eliminate cancers.

Also known as immuno-oncology these treatments work by training the immune system to identify and attack cancer cells, boost the immune cells, and enhance the immune response.

There are currently a range of immunotherapy options currently in use including targeted antibodies, cancer vaccines, adoptive cell transfer, tumour-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. Some are used in combination with other conventional therapies such as surgery, chemotherapy or radiotherapy.

Every patient responds differently to immunotherapy,  so treatments are different for every patient.  Biomarkers can be used to see if a cancer immunotherapy would be an effective treatment for specific patients. Research into how patients respond to treatments and patient reported outcome measures are important to understand which patients will potentially benefit from treatments.

Most therapies and treatments have side effects and immunotherapy side effects can be very different from standard cancer therapies as they result from stimulation of the immune system. Symptoms can range from inflammation and flu-like symptoms to more serious autoimmune disorders. The most common side effects include skin reactions, mouth sores, fatigue, nausea, body aches, headaches, and changes in blood pressure.

To find out more about immune -oncology and side effects, click on the links below: